Latest Institutional Purchases of Monte Rosa Therapeutics, Inc. (GLUE)
This list provides information on the latest institutional transactions involving Monte Rosa Therapeutics, Inc. (GLUE) stock that were buys. The list includes the name of the institution, the number of shares exchanged, the range of values for the transaction, and the number of shares held by the institution after the purchase has occurred.
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Jun 21, 2023
Q3 2021
|
Metropolitan Life Insurance CO
New York, NY |
BUY
|
- |
1.78K+ 97.69% |
$33.1K - $75K
|
3.6K
$30.5K
|
|
Nov 15, 2021
Q3 2021
|
Northwestern Mutual Wealth Management CO
|
BUY
|
- |
300New |
$5.58K - $12.7K
|
300
$2.55K
|
|
Q2 2021 | |||||||
Aug 06, 2021
Q2 2021
|
Aisling Capital Management LP
New York, NY |
BUY
|
- |
1.47MNew |
$27.8M - $33.4M
|
1.47M
$12.5M
|
|
Nov 14, 2022
Q2 2021
|
Alphabet Inc.
Mountain View, CA |
BUY
|
- |
1.46MNew |
$27.6M - $33.2M
|
1.46M
$12.4M
|
|
Aug 13, 2021
Q2 2021
|
Rtw Investments, LP
New York, NY |
BUY
|
- |
1.21MNew |
$22.9M - $27.6M
|
1.21M
$10.3M
|
|
Aug 16, 2021
Q2 2021
|
Alyeska Investment Group, L.P.
Chicago, IL |
BUY
|
- |
50KNew |
$943K - $1.14M
|
50K
$425K
|